Browsing Pharmacy Research by Subject "mTOR"
Now showing items 1-2 of 2
-
Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury.
( MDPI , 2019 , Article)Diabetic nephropathy (DN) is the most common cause of chronic kidney disease worldwide. Activation of signaling pathways such as the mammalian target of rapamycin (mTOR), extracellular signal-regulated kinases (ERK), ... -
Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases
( Hindawi , 2017 , Article)Sestrin2 (SESN2), a highly conserved stress-inducible metabolic protein, is known to repress reactive oxygen species (ROS) and provide cytoprotection against various noxious stimuli including genotoxic and oxidative stress, ...